These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2007-004981-42 Phase II study of sunitinib malate (SUTENT®) in relapsed germ cell tumors in males. bad-data
Ongoing 2014-001270-33 A treatment strategy of the Use of 1st line Chemotherapy in Patients with Poor-Prognosis Disseminated Non-Seminomatous Germ Cell Tumors based on tumor marker decline: A Phase II Trial of paclitaxel, i... not-yet-due
Ongoing 2016-000171-24 Phase II study of gemcitabine, carboplatin and VELIPARIB (ABT-888) in refractory testicular germ cell cancer. not-yet-due
Not reported 2016-004632-38 Phase II study of Avelumab in multiple relapsed/refractory testicular germ cell cancer. 2019-05-13 due-trials
Ongoing 2019-000558-68 Phase II study of disulfiram and cisplatin in refractory testicular germ cell cancer. not-yet-due
Ongoing 2019-001957-16 Phase II study of Vinorelbine, cisplatin, disulfiram and copper in CTC_EMT positive refractory metastatic breast cancer. not-yet-due